Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics.

被引：12

作者：

Liu Y. ^{[1
]}

Yang L. ^{[1
]}

机构：

[1] Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian

来源：

Journal of Zhejiang University SCIENCE B | 2006年 / 7卷 / 2期

关键词：

Traditional Chinese medicine (TCM); Metabolism; Gastrointestinal biotransformation;

D O I：

10.1631/jzus.2006.B0099

中图分类号：

学科分类号：

摘要：

Increasing attention is being paid to the scientific evaluation of traditional Chinese medicine (TCM). As many TCMs are capable of biotransformation in the gastrointestinal tract, attention to biotransformation of TCM in the gastrointestinal tract may lead to discovery of the active components and active mechanisms. In this article, we review reports that host metabolic enzymes and intestinal bacteria may be responsible for the metabolism of TCM. Good understanding of the in vivo course of TCM will help us to know how to conduct metabolism evaluation of TCM by using in vitro human-derived system. This evaluation system will create new views on TCM as effective and safe therapeutic agents.

引用

页码：99 / 106

页数：7

共 171 条

[31]

Pichard L.(2003)Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: implications for relating in vitro inhibition data to in vivo drug interactions Drug Metab. Dispos. 31 606-611

[32]

Domergue J.(2001)In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery Comb. Chem. High Throughput Screen 4 245-263

[33]

Maurel P.(2005)Gut micro-organisms, mammalian metabolism and personalized health care Nat. Rev. Microbiol. 3 431-438

[34]

Gonzalez F.P.(2001)Metabolic characterization of the major human small intestinal cytochrome P450s Drug Metab. Dispos. 29 347-352

[35]

Gunaratna C.(1996)First-pass metabolism of midazolam by the human intestine Clin. Pharmacol. Ther. 60 14-24

[36]

Hasegawa H.(2000)Indinavir concentrations and St. John’s Wort The Lancet 355 547-548

[37]

Holtbecker N.(1988)Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964∼1985) Br. J. Clin. Pharmacol. 25 387-396

[38]

Fromm M.F.(1997)Application of human liver microsomes in metabolism-based drug-drug interactions Adv. Pharmacol. 43 65-101

[39]

Kroemer H.K.(1997)Spontaneous hyphema associated with ingestion of Ginkgo biloba extract New Engl. J. Med. 336 1108-485

[40]

Ohnhms E.F.(2003)CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR Human Mutation 22 476-423

← 1 2 3 4 5 6 7 8 9 10 →